Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNM | ZTS | TAK | UTHR | NBIX |
| Company | Actinium Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.8300 | 196.80 | 14.87 | 344.57 | 123.00 |
| High | 1.9200 | 198.39 | 14.94 | 347.04 | 123.49 |
| Low | 1.7800 | 194.37 | 14.77 | 342.25 | 119.37 |
| Last | 1.7800 | 196.48 | 14.82 | 342.59 | 119.85 |
| Change | -0.0400 | +0.77 | -0.03 | -2.43 | -2.46 |
| % Change | -2.20% | +0.39% | -0.20% | -0.70% | -2.01% |
| Volume | 353,603 | 1,983,842 | 1,568,921 | 264,431 | 957,367 |
| 20-Day Average Volume | 392,040 | 1,684,157 | 1,655,391 | 395,697 | 1,159,268 |
| Previous Close | 1.8200 | 195.71 | 14.85 | 345.02 | 122.31 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9045 | 187.35 | 14.89 | 348.88 | 129.93 |
| 20-Day Raw Stochastic | 21.28% | 89.51% | 38.10% | 17.75% | 4.92% |
| 20-Day Relative Strength | 29.49% | 67.91% | 59.07% | 52.48% | 33.90% |
| Weighted Alpha | -52.44 | +15.48 | -0.59 | +60.63 | -4.24 |
| Today's Opinion | 100% Sell | 88% Buy | 72% Buy | 88% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 88% Buy | 40% Sell |
| Last Month's Opinion | 88% Sell | 72% Buy | 56% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.72% since 09/11/24 | +3.42% since 09/11/24 | unch since 09/11/24 | -1.04% since 09/11/24 | -1.33% since 09/11/24 |
| Low | 1.7500 on 09/16/24 | 187.14 on 09/12/24 | 14.66 on 09/13/24 | 337.52 on 09/13/24 | 119.37 on 09/18/24 |
| High | 2.0100 on 09/13/24 | 198.39 on 09/18/24 | 14.94 on 09/17/24 | 353.63 on 09/17/24 | 123.57 on 09/16/24 |
| 1-Month | |||||
| %Chg | -2.20% since 08/16/24 | +6.95% since 08/16/24 | +2.21% since 08/16/24 | +6.73% since 08/16/24 | -17.35% since 08/16/24 |
| Low | 1.6800 on 09/06/24 | 180.18 on 08/23/24 | 14.51 on 08/19/24 | 327.96 on 08/19/24 | 118.04 on 09/10/24 |
| High | 2.2800 on 08/20/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 154.87 on 08/23/24 |
| 3-Month | |||||
| %Chg | -77.38% since 06/18/24 | +15.81% since 06/18/24 | +16.97% since 06/18/24 | +11.94% since 06/18/24 | -8.41% since 06/18/24 |
| Low | 1.3300 on 08/05/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | 118.04 on 09/10/24 |
| High | 8.6400 on 07/23/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| 6-Month | |||||
| %Chg | -72.78% since 03/18/24 | +15.11% since 03/18/24 | +1.79% since 03/18/24 | +46.42% since 03/18/24 | -14.05% since 03/18/24 |
| Low | 1.3300 on 08/05/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 221.53 on 04/01/24 | 118.04 on 09/10/24 |
| High | 10.2400 on 05/14/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 366.08 on 09/03/24 | 157.98 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 54,205 | 89,301,504 | 46,997,832 | 15,303,704 | 12,308,911 |
| Shares Outstanding, K | 29,783 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 80,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -48,820,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 0 | 2,361,000,000 | 7,731,140,000 | 714,900,000 | 590,200,000 |
| Last Quarter Net Income | -8,670,000 | 624,000,000 | 609,590,000 | 278,100,000 | 65,000,000 |
| 60-Month Beta | 0.14 | 0.88 | 0.54 | 0.57 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 08/05/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 5.85 on 07/31/24 | 0.63 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 11/07/24 | 10/24/24 | 11/06/24 | 10/29/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 35.06 | 9.43 | 15.85 | 36.93 |